The effect of Rosiglitazone, a PPARgamma receptor agonist, on the NF-kappaB signaling pathway in acute hepatic injury induced by LPS.
- Author:
Li-juan LI
1
;
Rui-ling XU
Author Information
1. Jinci College, Shanxi Medical University, Taiyuan 030025, China. rjnancy2006@163.com
- Publication Type:Journal Article
- MeSH:
Acute Disease;
Animals;
Blotting, Western;
Disease Models, Animal;
I-kappa B Proteins;
metabolism;
Injections, Intraperitoneal;
Lipopolysaccharides;
Liver;
metabolism;
pathology;
Liver Diseases;
metabolism;
pathology;
Male;
Mice;
NF-kappa B;
metabolism;
NF-kappa B p50 Subunit;
metabolism;
PPAR gamma;
agonists;
Random Allocation;
Signal Transduction;
drug effects;
Thiazolidinediones;
pharmacology
- From:
Chinese Journal of Hepatology
2009;17(12):946-947
- CountryChina
- Language:Chinese
